Additionally, the CD44 expression in diverse cancer pathological stages was analyzed based on GEPIA database, as a result, CD44 expression related to the clinical pathological stages of breast invasive carcinoma (BRCA), pancreatic adenocarcinoma (PAAD), skin cutaneous melanoma (SKCM), and STAD (Figure 1D). This evidence concerns the gene CD44 and cancer.